Live feed/
Filings
/
SCHEDULE 13D/A
/
0001213900-26-094703
Stake: 19.35%
Shares: 3,057,488
CUSIP: M4119S187
Class: Ordinary shares, par value NIS 0.20 per share and American Depositary Shares, each representing one (1) Ordinary Share
Item 4 — Purpose of Transaction
Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On August 28, 2026, the Reporting Persons disseminated a communication to shareholders entitled "Response of L.I.A. Pure Capital and Invest-Pro to Evogene's August 25, 2026 Press Release." In such communication, the Reporting Persons expressed their views regarding the Issuer's performance, governance and board composition and encouraged shareholders to support the Reporting Persons' nominees for election to the Issuer's board of directors at the Issuer's upcoming annual meeting of shareholders. A copy of such communication is attached hereto as Exhibit 8 and is incorporated herein by reference. .
Cross-References
Insider Activity (last 365d)
1 transaction
1 buys · 0 sales · 0 awards/exercises
Issuer Cluster
11 13D/G filings on this issuer
10 other filings besides this one
Filer Track Record
16 filings by this filer
15 other filings in the data moat
Short Interest · settle 2026-09-30
DTC 1.00
932,725 shares short · +1541.9% vs prior
Form 4 Insider Transactions · last 365d
| Date | Insider | Role | Type | Shares | Price | Value |
|---|
| 2026-08-11 |
RECANATI LEON |
director |
Buy |
460,000 |
$0.64 |
$292K |
Other 13D/G Filings on Evogene Ltd.
| Filed | Form | Filer | Stake | Shares | |
|---|
| 2026-10-06 |
SCHEDULE 13D/A |
L.I.A. Pure Capital Ltd |
— |
3,057,488 |
view → |
| 2026-09-11 |
SCHEDULE 13D/A |
L.I.A. Pure Capital Ltd |
19.35% |
3,057,488 |
view → |
| 2026-09-11 |
SCHEDULE 13D/A |
RECANATI LEON |
8.60% |
1,354,836 |
view → |
| 2026-08-13 |
SCHEDULE 13D/A |
RECANATI LEON |
8.60% |
1,354,836 |
view → |
| 2026-08-13 |
SCHEDULE 13D/A |
L.I.A. Pure Capital Ltd |
— |
3,057,488 |
view → |
| 2026-08-11 |
SCHEDULE 13D |
RECANATI LEON |
5.70% |
894,836 |
view → |
| 2026-08-07 |
SCHEDULE 13D/A |
L.I.A. Pure Capital Ltd |
15.98% |
2,524,400 |
view → |
| 2026-07-27 |
SCHEDULE 13D/A |
L.I.A. Pure Capital Ltd |
17.41% |
2,308,100 |
view → |
| 2026-07-20 |
SCHEDULE 13D/A |
L.I.A. Pure Capital Ltd |
— |
2,228,100 |
view → |
| 2026-07-10 |
SCHEDULE 13D |
L.I.A. Pure Capital Ltd |
12.61% |
1,526,100 |
view → |
Other Filings by L.I.A. Pure Capital Ltd
| Filed | Form | Issuer | Stake | Shares | |
|---|
| 2026-10-06 |
SCHEDULE 13D/A |
Evogene Ltd. |
— |
3,057,488 |
view → |
| 2026-09-11 |
SCHEDULE 13D/A |
Evogene Ltd. |
19.35% |
3,057,488 |
view → |
| 2026-08-13 |
SCHEDULE 13D/A |
Evogene Ltd. |
— |
3,057,488 |
view → |
| 2026-08-07 |
SCHEDULE 13D/A |
Evogene Ltd. |
15.98% |
2,524,400 |
view → |
| 2026-07-27 |
SCHEDULE 13D/A |
Evogene Ltd. |
17.41% |
2,308,100 |
view → |
| 2026-07-20 |
SCHEDULE 13D/A |
Evogene Ltd. |
— |
2,228,100 |
view → |
| 2026-07-10 |
SCHEDULE 13D |
Evogene Ltd. EVGN |
12.61% |
1,526,100 |
view → |
| 2025-06-04 |
SCHEDULE |
XYLO TECHNOLOGIES LTD |
5.66% |
2,900,000 |
view → |
| 2020-12-03 |
SC |
Therapix Biosciences Ltd. SPRC |
— |
— |
view → |
| 2020-07-01 |
SC |
Therapix Biosciences Ltd. SPRC |
— |
— |
view → |
| 2020-06-26 |
SC |
Therapix Biosciences Ltd. SPRC |
— |
— |
view → |
| 2020-06-09 |
SC |
Medigus Ltd. |
— |
— |
view → |
| 2020-06-09 |
SC |
Therapix Biosciences Ltd. SPRC |
— |
— |
view → |
| 2020-04-28 |
SC |
Medigus Ltd. |
— |
— |
view → |
| 2019-03-18 |
SC |
BOS BETTER ONLINE SOLUTIONS LTD BOSC |
— |
— |
view → |
Want this depth on every filing the moment it hits SEC EDGAR?
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →